Drugs / potassium iodide

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) PERCHLORACAP 1974-11-21 fda.gov

Trials 9 · a red edge is where a trial was stopped

1974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/32 trials
Phase 2/3 NCT04804423 Jan 2020 → Mar 2021 dental caries, dentin sensitivity University Medicine Greifswald Completed No outcome recorded
Phase 2/3 NCT04236830 Nov 2019 → Mar 2021 dental pulp calcification, tooth hard tissue disease Nourhan M.Aly Completed No outcome recorded
Phase 32 trials
Phase 3 NCT02103998 Jul 2020 → May 2025 thyroid gland disorder New York Medical College Withdrawn No outcome recorded
Phase 3 NCT00379535 Dec 2006 → Dec 2008 pregnancy disorder University Hospital, Toulouse Terminated No outcome recorded
Phase 43 trials
Phase 4 NCT06699199 Nov 2023 → Jun 2025 overdue dental caries King Abdulaziz University Recruiting No outcome recorded
Phase 4 NCT04777968 Aug → Dec 2020 dental caries Cairo University Completed No outcome recorded
Phase 4 NCT04196829 Jan 2020 → Aug 2021 dental caries Cairo University Unknown No outcome recorded
Phase not applicable2 trials
NCT05628506 Jan 2023 → Dec 2025 thyroid gland disorder Prof. Gerasimos Sykiotis Unknown No outcome recorded
NCT04816487 May → Aug 2021 sensorineural hearing loss, retinal pigment epithelium lesions, discolored teeth Cairo University Unknown No outcome recorded
Also used as a comparator or background therapy in 8 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT06489093 Comparator Jul 2024 → May 2025 smooth surface dental caries Plovdiv Medical University Unknown No outcome recorded
Phase 11 trial
Phase 1 NCT03332667 Background Sep 2018 → Feb 2024 neuroblastoma New Approaches to Neuroblastoma Therapy Consortium Completed No outcome recorded
Phase 21 trial
Phase 2 NCT00490490 Background Jan 2007 → Jun 2011 non-Hodgkin lymphoma Stanford University Terminated No outcome recorded
Phase 32 trials
Phase 3 NCT02656329 Background Dec 2015 → May 2018 heart failure GE Healthcare Terminated No outcome recorded
Phase 3 NCT04080505 Comparator Feb 2015 → Mar 2023 Graves disease Columbia University Terminated No outcome recorded
Phase 41 trial
Phase 4 NCT00946296 Comparator Apr 2005 → Apr 2013 Graves disease University of Massachusetts, Worcester Completed No outcome recorded
Phase not applicable1 trial
NCT01850888 Background Dec 2013 → Oct 2025 neuroblastoma, pheochromocytoma Masonic Cancer Center, University of Minnesota Completed No outcome recorded
Phase not stated1 trial
NCT03649438 Background neuroblastoma, pheochromocytoma University of Texas Southwestern Medical Center No longer available No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 17 sources stand behind the page.

FieldValueCited text
Known as potassium iodide “immediately followed by a saturated Potassium Iodide KI solution using a micro brush also” NCT04777968
16

“Immediately afterwards, potassium iodide is applied as a reducing agent.” NCT06489093

Potassium IodideNCT02656329

NCT04236830

NCT04080505

NCT06699199

NCT00946296

NCT00379535

NCT03332667

NCT01850888

NCT05628506

NCT02103998

NCT04804423

NCT04196829

NCT00490490

NCT03649438

NCT04816487

Known as Potassium Perchlorate Potassium PerchlorateNCT02656329
Known as SSKI “The purpose of this study is to determine whether a brief course of SSKI (saturated solution of potassium iodide) administered preoperatively provides any benefit in the...” NCT00946296
1

SSKI (Potassium Iodide)” NCT04080505

Route Oral “per os” NCT00379535